Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-24T10:11:37.759Z Has data issue: false hasContentIssue false

A Colonization Outbreak of Penicillin-Susceptible mecA-Positive Staphylococcus aureus in a Neonatal Ward of Children’s Hospital

Published online by Cambridge University Press:  15 January 2018

Kisei Minami*
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Runa Terakawa
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Masanori Sato
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Yasuhiro Shoji
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Takehiko Hiroma
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Tomohiko Nakamura
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Ayaka Horiuchi
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Ayaka Otsuka
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Noriko Kubota
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Eiko Hidaka
Affiliation:
Nagano Children’s Hospital, Azumino, Japan
Yoshiyuki Kawakami
Affiliation:
Shinshu University Graduate School of Medicine, Matsumoto, Japan
Meiji Soe Aung
Affiliation:
Sapporo Medical University School of Medicine, Sapporo, Japan.
Nobumichi Kobayashi
Affiliation:
Sapporo Medical University School of Medicine, Sapporo, Japan.
*
Address correspondence to Kisei Minami, Toyoshina 3100, Azumino, Nagano prefecture, Japan (kiseiminami@gmail.com).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letters to the Editor
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

To the Editor—We experienced a colonization outbreak of penicillin-susceptible and mecA-positive Staphylococcus aureus strain in neonatal ward. After implementation of strict precautions and decolonization, the outbreak was terminated. To our knowledge, this is the first report of penicillin-susceptible MRSA outbreak in a neonatal ward.

Nagano Children’s Hospital is a tertiary pediatric hospital located in a rural area of Japan with 42 beds in the neonatal ward. Active weekly surveillance cultures of nares of inpatients of the neonatal ward have been carried out since the 1990s, especially for monitoring methicillin-resistant Staphylococcus aureus (MRSA). In recent years, the proportion of MRSA carriage in the neonatal ward has been approximately 0 to 5%.

In late July 2016, our surveillance system noticed an unusual surge in the colonization rate of methicillin-susceptible S. aureus (MSSA) in the neonatal ward. Detailed investigations revealed that this S. aureus strain has unique characteristics; namely, it is uniformly susceptible to penicillin but hetero-resistant to oxacillin and cefoxitin. Genetic analysis also revealed that this strain possesses the mecA gene; therefore, this strain was reassessed as MRSA, according to Clinical and Laboratory Standards Institute (CLSI) criteria. 1

The infection control team had emergency meetings and alerted healthcare workers throughout the hospital about the outbreak. The campaign for reinforcement of hand hygiene with contact precautions, strict isolation, and cohorting the patients was carried out. However, by the end of August, the colonization rate reached its the highest level (12 of 43 patients, 28%). We then decided to implement MRSA decolonization with mupirocin ointment. In total, 17 patients (12 penicillin-susceptible [PS] MRSA patients and 5 ‘ordinal’ MRSA carrier patients) had undergone the decolonization; 10 of 13 patients (76.9%) were confirmed as decolonized (defined as negative results for 2 consecutive cultures). Furthermore, 3 patients were not decolonized, and the other 4 patients were discharged before follow-up cultures were performed.

After these interventions, the carriage rate of PS-MRSA decreased, and no new cases of colonization were reported for 2 consecutive weeks. In late October, we declared that the outbreak had ended. Fortunately, there were no serious infections due to this PS-MRSA during this outbreak.

The outbreak strain of PS-MRSA did not yield typical cultures on MRSA-specific chromogenic media (CHROMagar II, Becton-Dickinson, Japan); on this selective medium, it yielded only a few slow-growing colonies, and sometimes the strain did not yield a culture on the medium. Antimicrobial susceptibility test showed resistance to gentamicin, erythromycin, and levofloxacin but susceptibility to vancomycin. The minimum inhibitory concentration (MIC) to oxacillin ranged from 0.25 to 4.0 µg/mL, and the MIC to cefoxitin ranged from 4.0 to 8.0 µg/mL, and the strain was assessed as susceptible to resistant. However, the MIC to penicillin was uniformly low, 0.03–0.12 µg/mL, and the strain was judged as susceptible according to CLSI criteria. 1 These MICs were measured using a broth microdilution test. The MICs to antimicrobial agents were also measured by E-test, and the results showed a similar tendency. The MICs to oxacillin, cefoxitin, and penicillin ranged from 0.25 to 8.0 µg/mL, from 4.0 to 24.0 µg/mL, and from 0.094 to 1.0 µg/mL, respectively.

Molecular subtyping and gene analyses, which were performed as described previously,Reference Kawaguchiya, Urushibara and Ghosh 2 , Reference Aung, Urushibara and Kawaguchiya 3 revealed that all the strains belonged to coa type IIa, SCCmec type I (type-1 ccr (A1, B1) and class B mec), sequence type (ST) 5, spa type t010, and agr group II. They did not possess Panton-Valentine leukocidin (PVL) or arginine catabolic mobile element (ACME) genes, but they harbored several hemolysins, enterotoxin gene clusters, and adhesins as shown in Table 1. On the other hand, these strains lacked mecI, mecR1, and blaZ genes.

TABLE 1 Molecular Characteristics of the Outbreak Strain

NOTE: ST, sequence type; ACME, arginine catabolic mobile element; PVL, Panton-Valentine leucocidin.

Genetic analyses of these strains revealed that mobile gene element IS 1182 was inserted within the promoter region of mecA gene in the class B SCCmec. Therefore, the mecA system of this strain was suggested to be nonfunctional. The sequence data were deposited in GenBank under accession nos. MF278653 and MF278654.

To our knowledge, this MRSA outbreak strain, ST5-SCCmec type I, has not been reported from clinical isolates in our country. SCCmec type I MRSA has seldom been isolated from clinical specimens since the 1990s, and its prevalence might be ~1%–5%.Reference Inomata, Yano and Tokuda 4

The emergence of this type of PS-MRSA poses several clinical problems. First, PS-MRSA could not be detected using a routine MRSA selection medium, so PS-MRSA might often be misrecognized as MSSA. Therefore, genetic analysis, such as polymerase chain reaction (PCR), is necessary for the detection of the mecA gene from S. aureus isolates, at least in serious infections. Second, an appropriate antimicrobial agent for PS-MRSA remains unknown. Moreover, there might be threat of converting from PS-MRSA to true (penicillin- and oxacillin-resistant) MRSA during treatment. The usual treatment regimen for MSSA infection with β-lactam antimicrobials might lead to treatment failure.Reference Proulx, Palace and Gandra 5

Exact prevalence of penicillin-susceptible or oxacillin-susceptible (PS/OS-) MRSA among clinically isolated MSSA is unknown, but it is supposed to be ~3%.Reference Proulx, Palace and Gandra 5 Literature on PS/OS-MRSA has been increasing all over the world.Reference Pournaras, Stathopoulos and Tsakris 6 , Reference Hososaka, Hanaki and Endo 7

The mechanisms of anomalous antimicrobial susceptibility of PS/OS-MRSA have not been fully elucidated.Reference Lowy 8 Several hypotheses have been proposed, such as amino acid changes in Fem proteins, which are responsible for Staphylococcal cell-wall synthesis,Reference Pournaras, Stathopoulos and Tsakris 6 partial excision of mecA gene,Reference Shore, Rossney and O’Connell 9 and bla system dysfunction.Reference Sabat, Pournaras and Akkerboom 10 PS/OS-MRSA strains are also quite diverse; therefore, many other novel mechanisms might be revealed. In consideration of its clinical importance, more attention should be given to penicillin- or oxacillin-susceptible, mecA-positive S. aureus.

ACKNOWLEDGMENTS

Financial support: No financial support was provided relevant to this article.

Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.

Footnotes

PREVIOUS PRESENTATION. A part of this manuscript was presented at the 35th Annual Meeting of the European Society for Paediatric Infectious Diseases, ESPID 2017, in Madrid, Spain, on May 25–26, 2017.

References

REFERENCES

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 25th informational supplement. CLSI document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.Google Scholar
2. Kawaguchiya, M, Urushibara, N, Ghosh, S, et al. Genetic diversity of emerging Panton–Valentine leukocidine/arginine catabolic mobile element (ACME)-positive ST8 SCCmec-IVa methicillin resistant Staphylococcus aureus (MRSA) strains and ACME-positive CC5 (ST5/ST764) MRSA strains in northern Japan. J Med Microbiol 2013;62:18521863.Google Scholar
3. Aung, MS, Urushibara, N, Kawaguchiya, M, et al. Virulence factors and genetic characteristics of methicillin-resistant and -susceptible Staphylococcus aureus isolates in Myanmar. Microb Drug Resist 2011;17:525535.Google Scholar
4. Inomata, S, Yano, H, Tokuda, K, et al. Microbiological and molecular epidemiological analyses of community-associated methicillin-resistant Staphylococcus aureus at a tertiary care hospital in Japan. J Infect Chemother 2015;21:729736.Google Scholar
5. Proulx, MK, Palace, SG, Gandra, S, et al. Reversion from methicillin susceptibility to methicillin resistance in Staphylococcus aureus during treatment of bacteremia. J Infect Dis 2016;213:10411048.CrossRefGoogle ScholarPubMed
6. Pournaras, S, Stathopoulos, C, Tsakris, A. Oxacillin-susceptible MRSA: could it become a successful MRSA type? Future Microbiol 2013;8:13651367.Google Scholar
7. Hososaka, Y, Hanaki, H, Endo, H, et al. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 2007;13:7986.Google Scholar
8. Lowy, FD. Antimicrobial resistance: the example of Staphylococcus aureus . J Clin Invest 2003;111:12651273.Google Scholar
9. Shore, AC, Rossney, AS, O’Connell, B, et al. Detection of Staphylococcal casette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA. Antimicrob Agents Chemother 2008;52:44074419.CrossRefGoogle Scholar
10. Sabat, AJ, Pournaras, S, Akkerboom, V, et al. Whole-genome analysis of an oxacillin-susceptible CC80 mecA-positive Staphylococcus aureus clinical isolate: insights into the mechanisms of cryptic methicillin resistance. J Antimicrob Chemother 2015;70:29562964.Google Scholar
Figure 0

TABLE 1 Molecular Characteristics of the Outbreak Strain